Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2020 08:00 ET | Source: Kalytera Therapeutics Inc.

Kalytera to Acquire Stero Biotechs, Ltd.

Acquisition Will Bring Kalytera Multiple Additional CBD Pharmaceutical Programs New Product Development Programs Will Address Large Commercial Opportunities in Steroid Sparing Kalytera Also...
February 19, 2020 22:52 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Modification to Sale Period for Shares Issued under Payments Agreement

SAN FRANCISCO, Calif. and TEL AVIV, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced a...
February 18, 2020 23:46 ET | Source: Kalytera Therapeutics Inc.

Kalytera Completes Share Issuance under Payments Agreement

SAN FRANCISCO and TEL AVIV, Israel, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
February 07, 2020 17:54 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces New Payments Agreement with the Salzman Group of Israel

SAN FRANCISCO and TEL AVIV, Israel, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
February 05, 2020 08:30 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Notice of Allowance of Additional U.S. Patent for Prevention and Treatment of Graft Versus Host Disease

SAN FRANCISCO and TEL AVIV, Israel, Feb. 05, 2020 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the United...
December 20, 2019 18:57 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Intention to Seek Amendment of Secured Convertible Debentures Due December 2019

SAN FRANCISCO and TEL AVIV, Israel, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has not...
December 16, 2019 08:00 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Extension of Maturity Date of Promissory Note

SAN FRANCISCO and TEL AVIV, Israel, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that, in...
December 02, 2019 08:30 ET | Source: Kalytera Therapeutics Inc.

Kalytera Reports Third Quarter 2019 Financial Results

SAN FRANCISCO, Calif. and TEL AVIV, Israel, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today reported financial...
November 22, 2019 08:30 ET | Source: Kalytera Therapeutics Inc.

Published Studies Provide Further Support For Kalytera’s Program Evaluating CBD in GVHD

SAN FRANCISCO and TEL AVIV, Israel, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that research...
October 30, 2019 22:10 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Closing of Final Tranche of Private Placement of Common Shares and Common Share Purchase Warrants and Amendments to Secured Convertible Debenture Units

SAN FRANCISCO and TEL AVIV, Israel, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera”) is pleased to announce that it has...